Have a feature idea you'd love to see implemented?
Let us know!
GHRS GH Research PLC
Price (delayed)
$9.62
Market cap
$500.51M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.79
Enterprise value
$411.18M
gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.
Highlights
GH Research's debt has decreased by 20% YoY and by 3.6% QoQ
The quick ratio fell by 42% YoY and by 21% QoQ
GH Research's net income has decreased by 18% from the previous quarter
Key stats
What are the main financial stats of GHRS
Market
Valuations
Earnings
Shares outstanding
52.03M
Market cap
$500.51M
Enterprise value
$411.18M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.64
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$40.7M
EBITDA
-$40.39M
Free cash flow
-$45.87M
Per share
Balance sheet
Liquidity
EPS
-$0.79
Free cash flow per share
-$0.88
Book value per share
$3.64
Revenue per share
$0
TBVPS
$3.84
Total assets
$199.61M
Total liabilities
$10.25M
Debt
$733,000
Equity
$189.37M
Working capital
$145.16M
Debt to equity
0
Current ratio
15.83
Quick ratio
15.33
Net debt/EBITDA
2.21
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-19.5%
Return on equity
-20.3%
Return on invested capital
-33.3%
Return on capital employed
-21.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GHRS stock price
How has the GH Research stock price performed over time
Intraday
-12.15%
1 week
7.25%
1 month
15.9%
1 year
64.44%
YTD
65.86%
QTD
43.8%
Financial performance
How have GH Research's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$48.53M
Net income
-$41.43M
Gross margin
N/A
Net margin
N/A
GH Research's operating income has decreased by 24% YoY and by 6% from the previous quarter
GH Research's net income has decreased by 18% from the previous quarter
Growth
What is GH Research's growth rate over time
Valuation
What is GH Research stock price valuation
P/E
N/A
P/B
2.64
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GHRS's EPS is down by 18% since the previous quarter
The price to book (P/B) is 20% more than the last 4 quarters average of 2.2
GH Research's equity has decreased by 16% YoY and by 4.7% QoQ
Efficiency
How efficient is GH Research business performance
GHRS's return on invested capital is down by 29% since the previous quarter and by 3.7% year-on-year
GHRS's return on equity is down by 24% since the previous quarter and by 18% year-on-year
The return on assets has declined by 23% since the previous quarter and by 16% year-on-year
Dividends
What is GHRS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GHRS.
Financial health
How did GH Research financials performed over time
GHRS's total liabilities has soared by 51% YoY and by 23% from the previous quarter
The quick ratio fell by 42% YoY and by 21% QoQ
GH Research's debt is 100% lower than its equity
GH Research's debt has decreased by 20% YoY and by 3.6% QoQ
GH Research's equity has decreased by 16% YoY and by 4.7% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.